Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Okamoto, Y. Miyazaki, K. Unoura, Y. Fujii, K. Tsuchiya, M. Tamaoka, H. Sakashita, Y. Sumi, N. Inase (Bunkyo-ku, Japan). Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease. Eur Respir J 2010; 36: Suppl. 54, 4175

Member's Comments

No comment yet.

Related content which might interest you: Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease Source: International Congress 2017 – Novel and old entities Year: 2017 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170 Year: 2007 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: International Congress 2019 – Lungs in the fog Year: 2019 Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP) Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006 Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009 Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Prevalence of progressive fibrosing interstitial lung disease Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 The natural history of progressive fibrosing interstitial lung diseases Source: Eur Respir J, 55 (6) 2000085; 10.1183/13993003.00085-2020 Year: 2020 Chronic hypersensitivity pneumonitis and its differential diagnosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189 Year: 2007 Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Pulmonary hypertension in hypersensitivity pneumonitis Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016